TELESCOPE- TELEhealth Shared Decision-making COaching

Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Aug 4, 2022

Keywords

ClinConnect Summary

The TELESCOPE trial is studying a new way to help patients make informed decisions about lung cancer screening. The goal is to see if providing personalized coaching from a health navigator can improve the quality of discussions about lung cancer screening compared to standard care. Researchers believe that this coaching will help patients understand the benefits and risks of screening better, lead to more conversations about getting screened, and encourage current smokers to seek help in quitting. They also want to find out if a follow-up coaching session can help patients stay on track with regular screenings.

To participate in this trial, you must be between 50 and 77 years old, a current or former smoker who quit within the last 15 years, and have a significant smoking history. You should also be scheduled for a non-emergency medical visit at one of the study sites. If you join, you can expect to receive support and guidance about lung cancer screening options and may have the chance to share your experiences in interviews or surveys. The TELESCOPE trial aims to enhance patient decision-making and improve lung cancer screening rates, ultimately helping to catch lung cancer earlier when it's easier to treat.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Inclusion Criteria Cluster Randomized Trial (N=420)
• Eligibility of patients for the cluster randomized trial will follow United States Preventive Services Task Force criteria for lung cancer screening. Specifically, patients must:
• • Be 50 to 77 years of age
• • Be a current or former smoker having quit within the past 15 years
• • Have at least a 20 pack-year smoking history
• • Be scheduled for a non-acute care visit at one of the study sites. Interviews (N=50)
• Participants completing the semi-structured interviews will be:
• • A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator (n=20) at one of the participating sites or a TELESCOPE study patient navigator (n=7) and nurse navigator (n = 3)
• • Age 18 or older
• • Fluent in English Online surveys (N=130)
• Providers completing online PRISM construct surveys will be:
• • A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator
• • Age 18 or older
• • Fluent in English
• Exclusion Criteria:
• • - Cluster Randomized Trial (N=420)
• Excluded will be patients who:
• • Do not speak English
• • Have a history lung cancer
• • Were screened for lung cancer within the past 12 months
• • Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider
• • Are unable to provide informed consent Interviews (N=50)
• Providers/administrators will be excluded if they:
• • Are unable to provide informed consent Online surveys (N=130)
• • Are unable to provide informed consent
• • Women who are pregnant. English proficiency is required for the completion of surveys, and the intervention will be conducted in English.